Literature DB >> 24742329

Delayed gastric emptying after esophagectomy for malignancy.

Bin Li1, Jian-Hua Zhang, Cheng Wang, Tie-Niu Song, Zhi-Qiang Wang, Yun-Jiu Gou, Jian-Bao Yang, Xiao-Ping Wei.   

Abstract

BACKGROUND: Controversy still exists about the need for pyloric drainage procedures after esophagectomy with gastric conduit reconstruction. Although pyloric drainage may prevent postoperative delayed gastric emptying (DGE), it may also promote dumping syndrome and bile reflux. The aims of this study were to audit the incidence and management of DGE in patients without routine pyloric drainage after esophagectomy in a university medical center. PATIENTS AND METHODS: From July 2006 to June 2012, data from 356 consecutive patients who underwent esophagectomy with a gastric conduit without pyloric drainage for esophageal or gastric cardia carcinoma were reviewed. Major observation parameters were the incidence, management, and outcomes of DGE.
RESULTS: Overall incidence of DGE was 15.7% (56 of 356). Early DGE developed in 26 patients, and late DGE developed in 30 patients. There were no differences in demographic and intraoperative data between the two groups with or without DGE. More DGE was documented in patients with an intra-right thoracic gastric conduit (P=.031). A higher incidence of postoperative pneumonia was observed in patients exhibiting early DGE, but without significance (P=.254). There were also no significant impacts on respiratory failure (P=.848) and anastomotic leakage (P=.257). There was an increased postoperative hospital stay with DGE, but without significance (P=.089). Endoscopic balloon dilatation of the pylorus was used to manage 33.9% of patients with DGE, yielding a 78.9% (15 of 19) success rate without complications. In 3 patients endoscopy showed the pylorus was open, and their symptoms improved over time. One patient with tumor-related DGE was treated by pyloric stent. The remaining patients were adequately treated with conservative management.
CONCLUSIONS: Omitting the operative drainage procedure does not lead to an increased frequency of DGE after esophagectomy with a gastric conduit. Many patients responded to conservative management, and endoscopic balloon pyloric dilatation can be effective in managing the DGE postoperatively.

Entities:  

Mesh:

Year:  2014        PMID: 24742329     DOI: 10.1089/lap.2013.0416

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  6 in total

Review 1.  Management of delayed gastric conduit emptying after esophagectomy.

Authors:  Rusi Zhang; Lanjun Zhang
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

2.  Treating Early Delayed Gastric Tube Emptying after Esophagectomy with Pneumatic Pyloric Dilation.

Authors:  Alexander Mertens; Jan Gooszen; Paul Fockens; Rogier Voermans; Suzanne Gisbertz; Arjan Bredenoord; Mark Ivo van Berge Henegouwen
Journal:  Dig Surg       Date:  2021-11-02       Impact factor: 2.588

3.  Pylorus drainage procedures in thoracoabdominal esophagectomy - a single-center experience and review of the literature.

Authors:  Stefan Fritz; Katharina Feilhauer; André Schaudt; Hansjörg Killguss; Eduard Esianu; René Hennig; Jörg Köninger
Journal:  BMC Surg       Date:  2018-03-01       Impact factor: 2.102

Review 4.  Symptom Management for Patients With Esophageal Cancer After Esophagectomy.

Authors:  Laura A Pachella; Susan Knippel
Journal:  J Adv Pract Oncol       Date:  2016-11-01

5.  Endoscopic dilation of benign post-esophagectomy anastomotic strictures: long-term outcomes and risk of recurrence.

Authors:  Mead Badir; Alain Suissa; Michael Orlovsky; Yousef Abu Asbeh; Iyad Khamaysi
Journal:  Ann Gastroenterol       Date:  2021-01-27

6.  Efficacy and safety of long-term transcutaneous electroacupuncture versus sham transcutaneous electroacupuncture for delayed gastric emptying after distal gastrectomy: study protocol for a randomized, patient-assessor blinded, controlled trial.

Authors:  Kai-Bo Chen; Zhi-Wei Wu; Jun Wang; Ling-Hua Zhu; Xiao-Li Jin; Guo-Feng Chen; Mu-Xing Kang; Yi Huang; Hang Zhang; Le-Le Lin; Di-Ke Shi; Dan Wu; Jian-Feng Chen; Jian Chen; Zhi-Qing Zhao
Journal:  Trials       Date:  2022-03-03       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.